Myung S. Kim, MD; Johnny Cai, DO; Ashray Maniar, MD; et al.
free access
JAMA Intern Med. 2022;182(1):76-78. doi:10.1001/jamainternmed.2021.4826
This cross-sectional study quantifies the number of randomized clinical trials in the literature for each indication for stem cell transplantation by disease type and status.
Charlene A. Wong, MD, MSHP; William Pilkington, DPA, MPA, PhD; Irene A. Doherty, PhD, MPH; et al.
free access
JAMA Intern Med. 2022;182(1):78-80. doi:10.1001/jamainternmed.2021.6170
This quasi-experimental study examines whether offering an incentive cash card to adults who receive or drive someone to receive their first dose of COVID-19 vaccine raises vaccination rates.
Aneel A. Ashrani, MD, MS; Daniel J. Crusan, BS; Tanya Petterson, MS; et al.
free access
JAMA Intern Med. 2022;182(1):80-83. doi:10.1001/jamainternmed.2021.6352
This cohort study compares the sex- and age-adjusted incidence of cerebral venous sinus thrombosis before the COVID-19 pandemic with that during the first 92 days after Ad26.COV2.S vaccination.
William B. Feldman, MD, DPhil, MPH; Benjamin N. Rome, MD, MPH; Beatrice L. Brown, MBE; et al.
free access
JAMA Intern Med. 2022;182(1):83-86. doi:10.1001/jamainternmed.2021.6445
This cross-sectional study analyzes a group of top-performing hospitals to quantify drug pricing variation across insurers.
Nancy Jariwala; Sydney Czako; Lindsey Brenton; et al.
free access
JAMA Intern Med. 2022;182(1):86-87. doi:10.1001/jamainternmed.2021.6594
This cross-sectional study examines undetectable heart sounds in hospitalized patients who are undergoing echocardiography and evaluates the association between patient factors and missed valvular heart disease diagnoses.
Jeremy Samuel Faust, MD, MS; Alexander Junxiang Chen; Max Jordan Nguemeni Tiako, MD, MS; et al.
free access
has active quiz
JAMA Intern Med. 2022;182(1):87-90. doi:10.1001/jamainternmed.2021.6734
This cohort study examines mortality data from Texas, a racially and ethnically diverse state, to better understand excess mortality among adults aged 25 to 44 years during early months of the COVID-19 pandemic.
Less Is More
John A. Vitarello, MD, MS; Clara J. Fitzgerald, MPH; Jennifer L. Cluett, MD; et al.
free access
JAMA Intern Med. 2022;182(1):90-93. doi:10.1001/jamainternmed.2021.6819
This cross-sectional study characterizes the prevalent use of medications that may raise BP and examine their associations with BP control and antihypertensive use.